TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III

BACKGROUND: Transmembrane protein 106B (TMEM106B) has been identified as a risk factor for frontotemporal lobar degeneration, which is the second most common form of progressive dementia in people under 65 years of age. Mutations in charged multivesicular body protein 2B (CHMP2B), which is involved...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Mol Brain
Huvudupphovsmän: Jun, Mi-Hee, Han, Jeong-Ho, Lee, Yu-Kyung, Jang, Deok-Jin, Kaang, Bong-Kiun, Lee, Jin-A
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2015
Ämnen:
Short Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4676093/
https://ncbi.nlm.nih.gov/pubmed/26651479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13041-015-0177-z
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk